Seddon’s Classification of Nerve Injuries

1. Neuropraxia:

   • Definition: This is the mildest form of nerve injury, often caused by compression or mild trauma.
   • Sunderland Classification: Type I (10).
   • Nerve Sheath: Intact; the surrounding connective tissue remains undamaged.
   • Axons: Intact; the nerve fibers are not severed.
   • Wallerian Degeneration: None; there is no degeneration of the distal nerve segment.
   • Conduction Failure: Transitory; there may be temporary loss of function, but it is reversible.
   • Spontaneous Recovery: Complete recovery is expected.
   • Time of Recovery: Typically within 4 weeks.

2. Axonotmesis:

   • Definition: This injury involves damage to the axons while the nerve sheath remains intact. It is often caused by more severe trauma, such as crush injuries.
   • Sunderland Classification: Type II (20), Type III (30), Type IV (40).
   • Nerve Sheath: Intact; the connective tissue framework is preserved.
   • Axons: Interrupted; the nerve fibers are damaged but the sheath allows for potential regeneration.
   • Wallerian Degeneration: Yes, partial; degeneration occurs in the distal segment of the nerve.
   • Conduction Failure: Prolonged; there is a longer-lasting loss of function.
   • Spontaneous Recovery: Partial recovery is possible, depending on the extent of the injury.
   • Time of Recovery: Recovery may take months.

3. Neurotmesis:

   • Definition: This is the most severe type of nerve injury, where both the axons and the nerve sheath are disrupted. It often results from lacerations or severe trauma.
   • Sunderland Classification: Type V (50).
   • Nerve Sheath: Interrupted; the connective tissue is damaged, complicating regeneration.
   • Axons: Interrupted; the nerve fibers are completely severed.
   • Wallerian Degeneration: Yes, complete; degeneration occurs in both the proximal and distal segments of the nerve.
   • Conduction Failure: Permanent; there is a lasting loss of function.
   • Spontaneous Recovery: Poor to none; recovery is unlikely without surgical intervention.
   • Time of Recovery: Recovery may begin by 3 months, if at all.

Early Complications

• Infection: Antibiotic prophylaxis, sterile technique
• Hematoma: Careful hemostasis, drainage if needed
• Dehiscence: Proper closure technique, patient education

Late Complications

• Neuroma formation: May require revision surgery
• Painful dysesthesia: Medications, nerve blocks
• Incomplete recovery: Sensory re-education, counseling
• Donor site problems: Usually minimal with sural nerve

Key Clinical Pearls

Decision Making

• Observation period: 3-6 months for incomplete injuries
• Surgical timing: Don't delay beyond 6-12 months
• Realistic expectations: Inform patients about limitations
• Documentation: Careful pre/post-operative assessment

Technical Points

• Graft length: Always harvest 25% longer than needed
• Suture technique: Epineural for sensory, perineural for mixed
• Magnification: Essential for successful repair
• Tension: Avoid at all costs, use grafts when needed

Follow-up Protocol

• Regular assessment: Sensory testing at intervals
• Long-term monitoring: Up to 2 years for full recovery
• Patient education: Signs of improvement vs complications
• Realistic timeline: Recovery is slow and often incomplete

Enophthalmos

Enophthalmos is a condition characterized by the inward sinking of the eye into the orbit (the bony socket that holds the eye). It is often a troublesome consequence of fractures involving the zygomatic complex (the cheekbone area).

Causes of Enophthalmos

Enophthalmos can occur due to several factors following an injury:

1. Loss of Orbital Volume:

   • There may be a decrease in the volume of the contents within the orbit, which can happen if soft tissues herniate into the maxillary sinus or through the medial wall of the orbit.

2. Fractures of the Orbital Walls:

   • Fractures in the walls of the orbit can increase the volume of the bony orbit. This can occur with lateral and inferior displacement of the zygoma or disruption of the inferior and lateral orbital walls. A quantitative CT scan can help visualize these changes.

3. Loss of Ligament Support:

   • The ligaments that support the eye may be damaged, contributing to the sinking of the eye.

4. Post-Traumatic Changes:

   • After an injury, fibrosis (the formation of excess fibrous connective tissue), scar contraction, and fat atrophy (loss of fat in the orbit) can occur, leading to enophthalmos.

5. Combination of Factors:

   • Often, enophthalmos results from a combination of the above factors.

Diagnosis

• Acute Cases: In the early stages after an injury, diagnosing enophthalmos can be challenging. This is because swelling (edema) of the surrounding soft tissues can create a false appearance of enophthalmos, making it seem like the eye is more sunken than it actually is.

Intraligamentary Injection and Supraperiosteal Technique

Intraligamentary Injection

• The intraligamentary injection technique is a simple and effective method for achieving localized anesthesia in dental procedures. It requires only a small volume of anesthetic solution and produces rapid onset of anesthesia.

• Technique:

  1. Needle Placement:
     • The needle is inserted into the gingival sulcus, typically on the mesial surface of the tooth.
     • The needle is then advanced along the root surface until resistance is encountered, indicating that the needle is positioned within the periodontal ligament.
  2. Anesthetic Delivery:
     • Approximately 0.2 ml of anesthetic solution is deposited into the periodontal ligament space.
     • For multirooted teeth, injections should be made both mesially and distally to ensure adequate anesthesia of all roots.

• Considerations:

  • Significant pressure is required to express the anesthetic solution into the periodontal ligament, which can be a factor to consider during administration.
  • This technique is particularly useful for localized procedures where rapid anesthesia is desired.

Supraperiosteal Technique (Local Infiltration)

• The supraperiosteal injection technique is commonly used for achieving anesthesia in the maxillary arch, particularly for single-rooted teeth.

• Technique:

  1. Anesthetic Injection:

     • For the first primary molar, the bone overlying the tooth is thin, allowing for effective anesthesia by injecting the anesthetic solution opposite the apices of the roots.

  2. Challenges with Multirooted Teeth:

     • The thick zygomatic process can complicate the anesthetic delivery for the buccal roots of the second primary molar and first permanent molars.
     • Due to the increased thickness of bone in this area, the supraperiosteal injection at the apices of the roots of the second primary molar may be less effective.

  3. Supplemental Injection:

     • To enhance anesthesia, a supplemental injection should be administered superior to the maxillary tuberosity area to block the posterior superior alveolar nerve.
     • This additional injection compensates for the bone thickness and the presence of the posterior middle superior alveolar nerve plexus, which can affect the efficacy of the initial injection.

Microvascular Trigeminal Decompression (The Jannetta Procedure)

Microvascular decompression (MVD), commonly known as the Jannetta procedure, is a surgical intervention designed to relieve the symptoms of classic trigeminal neuralgia by addressing the underlying vascular compression of the trigeminal nerve. This procedure is particularly effective for patients who have not responded to medical management or who experience significant side effects from medications.

Overview of the Procedure

1. Indication:

   • MVD is indicated for patients with classic trigeminal neuralgia, characterized by recurrent episodes of severe facial pain, often triggered by light touch or specific activities.

2. Anesthesia:

   • The procedure is performed under general anesthesia to ensure the patient is completely unconscious and pain-free during the surgery.

3. Surgical Approach:

   • The surgery is conducted using an intraoperative microscope for enhanced visualization of the delicate structures involved.
   • The arachnoid membrane surrounding the trigeminal nerve is carefully opened to access the nerve.

4. Exploration:

   • The trigeminal nerve is explored from its entry point at the brainstem to the entrance of Meckel’s cave, where the trigeminal ganglion (Gasserian ganglion) is located.

5. Microdissection:

   • Under microscopic and endoscopic visualization, the surgeon performs microdissection to identify and mobilize any arteries or veins that are compressing the trigeminal nerve.
   • The most common offending vessel is a branch of the superior cerebellar artery, but venous compression or a combination of arterial and venous compression may also be present.

6. Decompression:

   • Once the offending vessels are identified, they are decompressed. This may involve:
     • Cauterization and division of veins that are compressing the nerve.
     • Placement of Teflon sponges between the dissected blood vessels and the trigeminal nerve to prevent further vascular compression.

Outcomes and Efficacy

• Immediate Pain Relief:

  • Most patients experience immediate relief from facial pain following the decompression of the offending vessels.
  • Reports indicate rates of immediate pain relief as high as 90% to 98% after the procedure.

• Long-Term Relief:

  • Many patients enjoy long-term relief from trigeminal neuralgia symptoms, although some may experience recurrence of pain over time.

• Complications:

  • As with any surgical procedure, there are potential risks and complications, including infection, cerebrospinal fluid leaks, and neurological deficits. However, MVD is generally considered safe and effective.

• Latency period:
  • Adults: 5 – 7 days
  • Infants (8 months): 0 – 2 days
• Consolidation phase: Time between traction cessation & device removal
• Transport DO:
  • Trailing edge: Bone formation
  • Leading edge: Cartilage formation
• Midface distraction age: ≥3.5 years
• SARPE indication: Transverse expansion > 5 mm